Last updated on March 2018

Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Febrile Neutropenia
  • Age: Between 9 - 18 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Pediatric patients > 9 years old
  • Pediatric patients with solid tumors treated with cisplatin-based chemotherapy
  • Signing of Informed Consent from the parents
  • Signing of Informed Assent from the children

Non-inclusion Criteria:

  • Patients whose parents do not sign the Informed Consent
  • Patients with magnesium losing tubulopathy
  • Patients with hypomagnesemia previous to the cisplatin-based chemotherapy

Exclusion Criteria:

  • Patients whose parents retire the Informed Consent

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.